Incyte (INCY) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 137.65% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 36.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.61% |
| Dec 31, 2025 | 27.85% |
| Sep 30, 2025 | 81.51% |
| Jun 30, 2025 | 107.62% |
| Mar 31, 2025 | 20.36% |
| Dec 31, 2024 | 231.58% |
| Sep 30, 2024 | 84.44% |
| Jun 30, 2024 | -292.51% |
| Mar 31, 2024 | 285.88% |
| Dec 31, 2023 | -65.77% |
| Sep 30, 2023 | -37.79% |
| Jun 30, 2023 | 85.63% |
| Mar 31, 2023 | -158.76% |
| Dec 31, 2022 | 43.41% |
| Sep 30, 2022 | 20.46% |
| Jun 30, 2022 | 101.93% |
| Mar 31, 2022 | 8.19% |
| Dec 31, 2021 | 141.19% |
| Sep 30, 2021 | 21.10% |
| Jun 30, 2021 | -72.84% |
| Mar 31, 2021 | 125.58% |
| Dec 31, 2020 | -41.93% |
| Sep 30, 2020 | -35.91% |
| Jun 30, 2020 | 178.07% |
| Mar 31, 2020 | -625.98% |
| Dec 31, 2019 | 34.79% |
| Sep 30, 2019 | 64.76% |
| Jun 30, 2019 | 388.92% |
| Mar 31, 2019 | 1,565.81% |
| Dec 31, 2018 | 165.62% |
| Sep 30, 2018 | 85.82% |
| Jun 30, 2018 | -74.96% |
| Mar 31, 2018 | 104.24% |
| Dec 31, 2017 | -309.69% |
| Sep 30, 2017 | -46.71% |
| Jun 30, 2017 | 233.50% |
| Mar 31, 2017 | -311.59% |
| Dec 31, 2016 | 36.97% |
| Sep 30, 2016 | 3,224.37% |
| Jun 30, 2016 | -677.47% |
| Mar 31, 2016 | 1,230.03% |
| Dec 31, 2015 | 51.14% |
| Sep 30, 2015 | -145.69% |
| Jun 30, 2015 | 148.13% |
| Mar 31, 2015 | 76.31% |
| Dec 31, 2014 | 251.98% |
| Sep 30, 2014 | 196.82% |
| Jun 30, 2014 | -408.93% |
| Mar 31, 2014 | -244.09% |
| Dec 31, 2013 | -25.24% |
| Sep 30, 2013 | 53.76% |
| Jun 30, 2013 | -2.45% |
| Mar 31, 2013 | 143.43% |
| Dec 31, 2012 | 43.74% |
| Sep 30, 2012 | 42.79% |
| Jun 30, 2012 | 124.26% |
| Mar 31, 2012 | -22.61% |
| Dec 31, 2011 | -265.31% |
| Sep 30, 2011 | -60.59% |
| Jun 30, 2011 | -845.63% |
| Mar 31, 2011 | -143.67% |